{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:27:26Z","timestamp":1740130046606,"version":"3.37.3"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, Bethesda, MD"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,11]]},"DOI":"10.1093\/jnci\/djab160","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T19:10:51Z","timestamp":1628795451000},"page":"7-8","source":"Crossref","is-referenced-by-count":0,"title":["Another Weak Link in the Electron Transport Chain: Variants in <i>SUCLG2<\/i> and Risk for Pheochromocytoma and Paraganglioma"],"prefix":"10.1093","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6530-780X","authenticated-orcid":false,"given":"Gina M","family":"Ney","sequence":"first","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-1488","authenticated-orcid":false,"given":"Douglas R","family":"Stewart","sequence":"additional","affiliation":[{"name":"Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"2022011303095629900_djab160-B1","article-title":"Germline SUCLG2 variants in patients with pheochromocytoma and paraganglioma","author":"Hadrava Vanova","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2022011303095629900_djab160-B2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"issue":"7775","key":"2022011303095629900_djab160-B3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41586-019-1577-5","article-title":"alpha-Ketoglutarate links p53 to cell fate during tumour suppression","volume":"573","author":"Morris","year":"2019","journal-title":"Nature"},{"issue":"3","key":"2022011303095629900_djab160-B4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","article-title":"p53 represses the mevalonate pathway to mediate tumor suppression","volume":"176","author":"Moon","year":"2019","journal-title":"Cell"},{"issue":"7629","key":"2022011303095629900_djab160-B5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nature20132","article-title":"LKB1 loss links serine metabolism to DNA methylation and tumorigenesis","volume":"539","author":"Kottakis","year":"2016","journal-title":"Nature"},{"issue":"3","key":"2022011303095629900_djab160-B6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic KRAS maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"issue":"7443","key":"2022011303095629900_djab160-B7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"issue":"4","key":"2022011303095629900_djab160-B8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic heterogeneity in human lung tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"},{"issue":"7824","key":"2022011303095629900_djab160-B9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer SLC43A2 alters T cell methionine metabolism and histone methylation","volume":"585","author":"Bian","year":"2020","journal-title":"Nature"},{"issue":"7788","key":"2022011303095629900_djab160-B10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"issue":"8","key":"2022011303095629900_djab160-B11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","article-title":"Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair","volume":"50","author":"Sulkowski","year":"2018","journal-title":"Nat Genet"},{"issue":"7","key":"2022011303095629900_djab160-B12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2022011303095629900_djab160-B13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"7831","key":"2022011303095629900_djab160-B14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","article-title":"Exome sequencing and characterization of 49,960 individuals in the UK Biobank","volume":"586","author":"Van Hout","year":"2020","journal-title":"Nature"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djab160\/40391926\/djab160.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/1\/7\/42150871\/djab160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/114\/1\/7\/42150871\/djab160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T03:10:24Z","timestamp":1642043424000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/114\/1\/7\/6355592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,20]]},"published-print":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djab160","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"type":"print","value":"0027-8874"},{"type":"electronic","value":"1460-2105"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,20]]}}}